0001161697-24-000256.txt : 20240607
0001161697-24-000256.hdr.sgml : 20240607
20240607170008
ACCESSION NUMBER: 0001161697-24-000256
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: INGENITO GARY
CENTRAL INDEX KEY: 0001279473
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 241030456
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1500
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 06-05-2024
X0508
4
2024-06-05
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001279473
INGENITO GARY
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
Chief Med. & Reg. Officer
0
Common stock, par value $0.001 per share
2024-06-05
4
M
0
80000
4.01
A
131391
D
Common stock, par value $0.001 per share
2024-06-05
4
S
0
80000
16.16
D
51391
D
Options to purchase common stock
4.01
2024-06-05
4
M
0
80000
0
D
2025-01-02
Common Stock
80000
1050575
D
Dr. Ingenito sold the shares on the open market to for personal reasons and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a result of any disagreement with the Company.
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.11 to $16.27 per share.
Options vested in three annual tranches beginning on January 2, 2019.
/s/ Gary Ingenito
2024-06-07